Magnetic nanoparticles in cancer therapy and diagnosis
There is urgency for the development of nanomaterials that can meet emerging biomedical
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …
needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface‐area‐to …
Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy
Magnetic nanoparticles have received tremendous attention in diverse fields because of
their unique nanoscale physicochemical properties and the potential for a wide range of …
their unique nanoscale physicochemical properties and the potential for a wide range of …
[HTML][HTML] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Background Men with high serum prostate specific antigen usually undergo transrectal
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
ESUR prostate MR guidelines 2012
JO Barentsz, J Richenberg, R Clements, P Choyke… - European …, 2012 - Springer
The aim was to develop clinical guidelines for multi-parametric MRI of the prostate by a
group of prostate MRI experts from the European Society of Urogenital Radiology (ESUR) …
group of prostate MRI experts from the European Society of Urogenital Radiology (ESUR) …
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound–guided biopsy versus magnetic resonance (MR) imaging with …
MR Pokorny, M De Rooij, E Duncan, FH Schröder… - European urology, 2014 - Elsevier
Background The current diagnosis of prostate cancer (PCa) uses transrectal ultrasound–
guided biopsy (TRUSGB). TRUSGB leads to sampling errors causing delayed diagnosis …
guided biopsy (TRUSGB). TRUSGB leads to sampling errors causing delayed diagnosis …
A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy
Modern cancer diagnosis requires histological, molecular, and genomic tumor analyses.
Tumor sampling is often achieved using a targeted needle biopsy approach. Targeting …
Tumor sampling is often achieved using a targeted needle biopsy approach. Targeting …
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting
L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey… - European urology, 2011 - Elsevier
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) may have a role in
detecting clinically significant prostate cancer in men with raised serum prostate-specific …
detecting clinically significant prostate cancer in men with raised serum prostate-specific …
Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US–MR fusion guidance versus systematic biopsy—prospective …
P Puech, O Rouvière, R Renard-Penna, A Villers… - Radiology, 2013 - pubs.rsna.org
Purpose To compare biopsy performance of two approaches for multiparametric magnetic
resonance (MR)-targeted biopsy (TB) with that of extended systematic biopsy (SB) in …
resonance (MR)-targeted biopsy (TB) with that of extended systematic biopsy (SB) in …
Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study
F Bratan, E Niaf, C Melodelima, AL Chesnais… - European …, 2013 - Springer
Objectives To assess factors influencing prostate cancer detection on multiparametric (T2-
weighted, diffusion-weighted, and dynamic contrast-enhanced) MRI. Methods One hundred …
weighted, diffusion-weighted, and dynamic contrast-enhanced) MRI. Methods One hundred …
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients …
F Porpiglia, M Manfredi, F Mele, M Cossu, E Bollito… - European urology, 2017 - Elsevier
Background An approach based on multiparametric magnetic resonance imaging (mpMRI)
might increase the detection rate (DR) of clinically significant prostate cancer (csPCa) …
might increase the detection rate (DR) of clinically significant prostate cancer (csPCa) …